Sara Matarazzo

656 total citations
13 papers, 522 citations indexed

About

Sara Matarazzo is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Sara Matarazzo has authored 13 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Sara Matarazzo's work include Fibroblast Growth Factor Research (7 papers), Biomarkers in Disease Mechanisms (6 papers) and Kruppel-like factors research (4 papers). Sara Matarazzo is often cited by papers focused on Fibroblast Growth Factor Research (7 papers), Biomarkers in Disease Mechanisms (6 papers) and Kruppel-like factors research (4 papers). Sara Matarazzo collaborates with scholars based in Italy, United States and United Kingdom. Sara Matarazzo's co-authors include Arianna Giacomini, Roberto Ronca, Marco Presta, Silvia Biocca, Emanuela Di Salle, Sara Rezzola, Marco Mor, Daniela Coltrini, Marco Rusnati and Giuseppe Novelli and has published in prestigious journals such as Cancer Cell, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Sara Matarazzo

13 papers receiving 518 citations

Peers

Countries citing papers authored by Sara Matarazzo

Since Specialization

Citations

This map shows the geographic impact of Sara Matarazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Matarazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Matarazzo more than expected).

Fields of papers citing papers by Sara Matarazzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Matarazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Matarazzo. The network helps show where Sara Matarazzo may publish in the future.

Co-authorship network of co-authors of Sara Matarazzo

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Matarazzo. A scholar is included among the top collaborators of Sara Matarazzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Matarazzo. Sara Matarazzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 2021 ·European Journal of Medicinal Chemistry ·Riccardo Castelli, (unknown), (unknown), (unknown), (unknown), Francesca Ferlenghi, Silvia Rivara, Michele Retini, Annalida Bedini, Gilberto Spadoni, Sara Matarazzo, Roberto Ronca, Marco Presta, Marco Mor, Arianna Giacomini	5
2	FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation–Induced Mitochondrial Oxidative Stress 2020 ·Cancer Research ·Roberto Ronca, Gaia C. Ghedini, Federica Maccarinelli, Antonio Sacco, Silvia L. Locatelli, Eleonora Foglio, (unknown), Elisabetta Grillo, Sara Matarazzo, Riccardo Castelli, (unknown), Vanessa Desantis, Nadia Cattane, Annamaria Cattaneo, Marco Mor, Carmelo Carlo‐Stella, Angelo Belotti, Aldo M. Roccaro, Marco Presta, Arianna Giacomini	43
3	Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress 2020 ·International Journal of Molecular Sciences ·Arianna Giacomini, (unknown), Sara Rezzola, Sara Matarazzo, Elisabetta Grillo, Mattia Bugatti, (unknown), Jessica Guerra, Martina Di Trani, Marco Presta, Roberto Ronca	25
4	Long Pentraxin-3 Follows and Modulates Bladder Cancer Progression 2019 ·Cancers ·Sara Matarazzo, Laura Melocchi, Sara Rezzola, Elisabetta Grillo, Federica Maccarinelli, Arianna Giacomini, (unknown), (unknown), Luca Zammataro, Marianna Cerasuolo, Mattia Bugatti, William Vermi, Marco Presta, Roberto Ronca	22
5	Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 2018 ·Frontiers in Oncology ·(unknown), Sara Matarazzo, Federica Maccarinelli, Eleonora Foglio, Arianna Giacomini, João Paulo Silva Nunes, Marco Presta, Adriana Abalen Martins Dias, Roberto Ronca	22
6	Blocking the FGF/FGFR system as a two-compartment antiangiogenic/antitumor approach in cancer therapy 2016 ·Pharmacological Research ·Arianna Giacomini, Paola Chiodelli, Sara Matarazzo, Marco Rusnati, Marco Presta, Roberto Ronca	67
7	Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 2016 ·Journal of Medicinal Chemistry ·Riccardo Castelli, Arianna Giacomini, (unknown), (unknown), Federica Vacondio, Silvia Rivara, Sara Matarazzo, Marco Presta, Marco Mor, Roberto Ronca	30
8	Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 2015 ·Cancer Cell ·Roberto Ronca, Arianna Giacomini, Emanuela Di Salle, Daniela Coltrini, Katiuscia Pagano, Laura Ragona, Sara Matarazzo, Sara Rezzola, Daniele Maiolo, Rubben Torella, Elisabetta Moroni, Roberta Mazzieri, Giulia Escobar, Marco Mor, Giorgio Colombo, Marco Presta	6
9	Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 2015 ·Cancer Cell ·Roberto Ronca, Arianna Giacomini, Emanuela Di Salle, Daniela Coltrini, Katiuscia Pagano, Laura Ragona, Sara Matarazzo, Sara Rezzola, Daniele Maiolo, Rubben Torella, Elisabetta Moroni, Roberta Mazzieri, Giulia Escobar, Marco Mor, Giorgio Colombo, Marco Presta	101
10	Molecular mechanism of statin-mediated LOX-1 inhibition 2015 ·Cell Cycle ·Silvia Biocca, Federico Iacovelli, Sara Matarazzo, Giulia Vindigni, Francesco Oteri, Alessandro Desideri, Mattia Falconi	47
11	A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 2015 ·Oncotarget ·Arianna Giacomini, Sara Matarazzo, Katiuscia Pagano, Laura Ragona, Sara Rezzola, Michela Corsini, Emanuela Di Salle, Marco Presta, Roberto Ronca	25
12	Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells 2013 ·Molecular Cancer Therapeutics ·Roberto Ronca, Emanuela Di Salle, Arianna Giacomini, Daria Leali, Patrizia Alessi, Daniela Coltrini, Cosetta Ravelli, Sara Matarazzo, Doménico Ribatti, William Vermi, Marco Presta	62
13	Cholesterol-Lowering Drugs Inhibit Lectin-Like Oxidized Low-Density Lipoprotein-1 Receptor Function by Membrane Raft Disruption 2012 ·Molecular Pharmacology ·Sara Matarazzo, (unknown), Ruggiero Mango, Sarah Ciccone, Giuseppe Novelli, Silvia Biocca	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact